Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 Short-Term Catalysts Make Galena Biopharma A Long-Term Buy
Seeking Alpha
Sunday, November 3, 2013 - 12:03pm
tags:
Galena Biopharma
Dr.Reddy’s wins trademark case against Reddy Pharma
The Hindu, India
Saturday, November 2, 2013 - 12:08pm
tags:
Dr Reddy's, lawsuits
Manufacturing Sold Separately? Dendreon's Plan B.
Motley Fool
Saturday, November 2, 2013 - 12:06pm
tags:
Dendreon
1 Big Pharma Giant on the Verge of a Turnaround
Motley Fool
Saturday, November 2, 2013 - 11:58am
tags:
Sanofi
Bristol seeks Japan approval of all-oral hepatitis C treatment
Yahoo/Reuters
Saturday, November 2, 2013 - 11:56am
tags:
Bristol-Myers Squibb, daclatasvir, asunaprevir, hepatitis C, hepatitis
Merck Announces Presentation of Interim Data from Study of Investigational Combination of HCV Therapies MK-5172 and MK-8742 at the 2013 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
Yahoo/BusinessWire
Saturday, November 2, 2013 - 11:40am
tags:
MK-5172, MK-8742, hepatitis C, hepatitis
Elan Investors Ask SAC Capital Judge Insist on Admission
Bloomberg
Saturday, November 2, 2013 - 11:38am
tags:
Elan
This Week in Biotech: Twitter Edition
Motley Fool
Saturday, November 2, 2013 - 11:36am
tags:
Gilead Sciences, PDL Biopharma, Depomed, Vertex Pharmaceuticals, JNJ, Sarepta Therapeutics
Conatus Pharmaceuticals Presents Data Demonstrating Emricasan's Safety Profile at the AASLD Liver Meeting(R)
Yahoo/Globe Newswire
Saturday, November 2, 2013 - 11:31am
tags:
emricasan, Conatus Pharmaceuticals
Gilead Announces Phase 3 Results for an All-Oral, Sofosbuvir-Based Regimen for the Treatment of Hepatitis C in Patients Co-Infected With HIV
Yahoo/BusinessWire
Saturday, November 2, 2013 - 11:28am
tags:
Gilead, hepatitis C, sofosbuvir
Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex
Yahoo/24-7 Wallstreet
Saturday, November 2, 2013 - 11:27am
tags:
IDX20963, hepatitis C, hepatitis
Androxal Makes Repros A Buy
Seeking Alpha
Saturday, November 2, 2013 - 11:25am
tags:
Androxal, Repros Therapeutics, hypogonadism
When Japanese Pharma Report, These American Biotechs React
Motley Fool
Saturday, November 2, 2013 - 11:22am
tags:
Arena Pharmaceuticals, Medivation, JNJ, Vivus, Astellas, Eisai
Cytokinetics: 2014 Will Bring Critical Data Readouts On Tirasemtiv And Omecamtiv Mecarbil
Seeking Alpha
Saturday, November 2, 2013 - 11:19am
tags:
Tirasemtiv, Omecamtiv Mecarbil, Cytokinetics
Vertex Pharmaceuticals: Filling in the Gap
Barron's
Saturday, November 2, 2013 - 11:16am
tags:
Vertex Pharmaceuticals
FDA helps generic drugmakers get copies of Glaxo's Advair to market
Fierce Pharma
Friday, November 1, 2013 - 4:50pm
tags:
FDA, generics, Advair, GSK
Incyte Earnings Show Product and Pipeline Progress
Motley Fool
Friday, November 1, 2013 - 4:47pm
tags:
Incyte, earnings
Does Sequenom Have Any Future After Court Ruling?
Seeking Alpha
Friday, November 1, 2013 - 4:45pm
tags:
Sequenom, Ariosa, Downs Syndrome
KCI Completes Acquisition of Systagenix
CP Wire
Friday, November 1, 2013 - 4:38pm
tags:
M&A, KCI, Systagenix, wound care
FDA approves Roche leukemia drug Gazyva
Reuters
Friday, November 1, 2013 - 11:48am
tags:
FDA, Roche, Gazyva, chronic lymphocytic leukemia, CLL

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.